| abstract |
(57) [Summary]nFragments of von Willebrand factor (vWF) containing the platelet glycoprotein Ib (GPIb) binding domain are used in combination with known therapeutic methods to enhance protection against thrombus, improve thrombolysis, reocclusion after thrombolytic therapy, etc. Methods are provided to achieve a reduction in the symptoms of. In addition, the use of the vWF fragment and aspirin also provides a method of preventing complications after traumatic vessel injury. |